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Biogenesis and Function of Circular
RNAs in Health and in Disease
George Haddad* and Johan M. Lorenzen*
Division of Nephrology, University Hospital Zürich, Zurich, Switzerland
Circular RNAs (circRNAs) are a class of non-coding RNA that were previously thought
to be insignificant byproducts of splicing errors. However, recent advances in RNA
sequencing confirmed the presence of circRNAs in multiple cell lines and across different
species suggesting a functional role of this RNA species. CircRNAs arise from back-
splicing events resulting in a circular RNA that is stable, specific and conserved. They
can be generated from exons, exon-introns, or introns. CircRNAs have multifaceted
functions. They are likely part of the competing endogenous RNA class. They can
regulate gene expression by sponging microRNAs, binding proteins or they can be
translated into a protein themselves. CircRNAs have been associated with health and
disease, some with disease protective effects, some with disease promoting functions.
The widespread expression and disease regulatory mechanisms endow circRNAs to be
used as functional biomarkers and therapeutic targets for a variety of different disorders.
In this concise article we provide an overview of the association of circRNAs with
various diseases including cancer, cardiovascular and kidney disease as well as cellular
senescence. We conclude with an assessment of the current status and future outlook
of this new field of research that carries immense potential with respect to diagnostic
and therapeutic approaches of a variety of diseases.
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INTRODUCTION
Cellular ribonucleic acids are a family of coding and non-coding sequences. Merely 1–2% of the
human genome is transcribed into RNA transcripts, which are translated into protein (Lorenzen
and Thum, 2016; Brandenburger et al., 2018). Aside from mRNA which represents 3–7% (Hastie
and Bishop, 1976; Carter et al., 2005) of the total RNA species in mammalian cells, the majority
of the RNA species are of the non-coding category that include ribosomal RNA (rRNA) (80–
90% Wolf and Schlessinger, 1977; Duncan and Hershey, 1983; Palazzo and Lee, 2015), transfer
RNA (tRNA) (10–15%; Waldron and Lacroute, 1975; Palazzo and Lee, 2015), long non-coding
RNA (0.06–0.2%; Mortazavi et al., 2008; Palazzo and Lee, 2015), microRNA (0.003–0.02%; Bissels
et al., 2009; Palazzo and Lee, 2015), and circular RNA (circRNA) (0.002–0.03%; Salzman et al.,
2012; Palazzo and Lee, 2015) among others. Non-coding RNAs (ncRNAs) are separated into
long ncRNAs (lncRNAs, ≥200 nucleotides) and small ncRNAs (≤200 nucleotides). Small RNAs
including microRNAs, which lead to the repression of gene/protein expression and/or translational
inhibition of protein synthesis by post-transcriptional binding of the 3′-untranslated region (UTR)
of mRNA targets, have been extensively studied over the past several years (Lorenzen and Thum,
2016; Brandenburger et al., 2018). In contrast, only little information is available regarding
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the functional importance of long non-coding RNAs (lncRNAs).
It is becoming evident that lncRNAs are important epigenetic
regulators of tissue homeostasis during development and
disease (Lorenzen and Thum, 2016; Brandenburger et al.,
2018). LncRNAs may be categorized as: (1) sense or (2)
antisense, (3) bidirectional promoter (transcribed within 1 kb of
promoters antisense to protein-coding transcript), (4) intronic,
(5) intergenic, or (6) enhancer-associated (transcribed from an
enhancer region of a protein-coding gene) (Lorenzen and Thum,
2016; Brandenburger et al., 2018). In addition, circular RNAs
have been identified as part of the lncRNA class. These RNAs are
characterized by a circular structure in which the 3′ and 5′ ends
are covalently linked. In the present article we aim to elaborate on
the biogenesis of this newly identified RNA class as well as discuss
its potential function.
Circular RNAs are diverse RNA species that are found in all
live forms from archaea to humans (Danan et al., 2012; Jeck
et al., 2013; Haque and Harries, 2017). Although, circRNAs have
been discovered over 20 years ago they were initially dismissed
for having low abundance or resulting from splicing errors
(Salzman et al., 2012; Jeck and Sharpless, 2014; Zheng et al., 2016).
However, recent advancements in high throughput sequencing
revealed the presence of circRNAs in mammalian cells, across
various cell lines and many transcripts are abundant and stable
(Jeck and Sharpless, 2014; Haque and Harries, 2017). CircRNAs
are generated through a mechanism known as back-splicing “tail”
to “head” whereby an exon at the 3′end of a gene is back-spliced to
an exon at the 5′end of the gene resulting in a circular RNA form
(Cocquerelle et al., 1993). CircRNAs are dispersed throughout
the genome. They can arise mainly from exons but circRNAs
deriving from inter- or intragenic, and intronic regions as well as
antisense sequences have been reported (Cocquerelle et al., 1993;
Lan et al., 2016).
It is imperative to distinguish valid circular RNA from
artifact circular RNA. Jeck and Sharpless (2014) argued that
backsplice events can occur not only from exonic circRNAs but
also can be generated through other mechanisms such as RT-
PCR template switching, RNA trans-splicing, as well as tandem
duplication. Therefore, methods to validate the circularity of an
RNA are essential.
Several methods have been described to separate linear
from circRNAs. In general circRNAs do not have a 3′end
as compared to linear exonic RNA and they migrate slower
in a two-dimensional polyacrylamide gel (Tabak et al., 1988).
RNA degradation by RNase H or weak hydrolysis can offer a
more conclusive method for RNA circularity by linearizing the
circRNAs into one product (Capel et al., 1993). In addition, other
enzymes that degrade RNA can be employed such as RNase R
exonuclease, and terminator exonuclease which have no effect on
the circRNAs but degrade the majority of linear RNA (Suzuki
et al., 2006; Hansen et al., 2011, 2013; Jeck and Sharpless, 2014).
Similarly, circRNAs must be distinguished from RNA
lariats which are generated through canonical RNA splicing
and resemble exonic circRNAs. However, lariat RNAs are
distinguished by the presence of a 2′–5′junction in contrast to
the 3′–5′linkage present in exonic circRNAs. Due to this linkage
difference RNA lariats can be depleted by treatment with RNA
lariat debranching enzyme followed by exonuclease digestion
(Ruskin and Green, 1990; Zhang et al., 2013; Jeck and Sharpless,
2014). CircRNA biogenesis is schematically shown in Figure 1.
Cellular Source of circRNA
Genome-wide analyses establish a strong evidence of circRNA
presence in various cell types (Salzman et al., 2012; Zhang
et al., 2013; Jeck and Sharpless, 2014). The expression of
circRNAs is prevalent, specific, stable, and displays a temporal
and spatial regulation suggesting tissue specific function under
physiological and pathological conditions (Wang et al., 2014;
Xu et al., 2017; Fang, 2018). They have higher expression levels
in low-proliferating cells such as in the brain as compared
to high-proliferating cells of the liver (Bachmayr-Heyda et al.,
2015). Moreover, in hematopoietic cells including progenitors,
differentiated myeloid and lymphoid cells, circRNA expression
can be cell specific and increases during cellular maturation.
Interestingly, enucleated cells such as red blood cells and platelets
appear to express higher levels of circRNAs as compared to
nucleated hematopoietic cells (Nicolet et al., 2018). It was
found that platelets, in particular, express the highest number
of circRNAs, almost twice as much as erythrocytes and 5 times
more than granulocytes (Nicolet et al., 2018). Taken together,
this suggests that circRNAs may play an important role in
maintaining erythrocyte and platelet function in responding
to micro-environmental cues and to cross-talk with other cell
types through the packaging of circRNAs into microvesicles,
or exosomes (Nicolet et al., 2018). Exosomes are vesicles that
pinch off the plasma membrane, sized between 40 and 150 nm
in diameter where intracellular materials can be packaged and
delivered as messenger shuttles between cells (Properzi et al.,
2013; Raposo and Stoorvogel, 2013). Interestingly, the expression
levels of select circRNAs in exosomes derived from cancerous
tissue is higher than in non-cancer derived exosomes (Li Y.
et al., 2015). Exosomes are generated through the exosomal
pathway that involves the expression of distinct protein markers
not present in other vesicles of comparable size. These markers
include tetraspanins (TSPAN27, 28, and 29), Tsg101 and Alix
from the Rab family of proteins, and heat shock proteins such
as HSP70 (Bobrie et al., 2011). The prevalence of circRNAs in
extracellular exosomes is proposed to serve as reliable biomarkers
in diagnosing various diseases and also assessing the efficacy of a
certain treatment (Van Der Pol et al., 2012; Abu and Jamal, 2016).
EXONIC circRNA HYPOTHESIZED
FUNCTIONS
The evidence on the molecular and cellular functions of circRNAs
is emerging. However, regarding the vast majority of circular
RNA species their biogenesis, targets and regulation are still
not well understood (Vicens and Westhof, 2014; Salzman,
2016). The cellular location of certain circRNAs may provide
an indication of their function. Many exonic circRNAs with
retained introns as well as circular intronic RNAs (ciRNAs) are
found predominantly in the nucleus suggesting a transcription
regulatory function (Li Z. et al., 2015; Huang et al., 2017),
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FIGURE 1 | Schematic representation of circRNAs generation and function. elF4G2, initiation factor eukaryotic translation initiation factor 4 gamma; METTL3,
methyltransferase-like 3; METTL14, methyltransferase-like 14.
whereas, circRNAs that are generated from exons only are mostly
found in the cytoplasm, which may insinuate a role in post-
transcriptional gene regulation (Salzman et al., 2012; Jeck et al.,
2013; Wilusz, 2018).
The circRNA-sponging function of miRNA is well
characterized in the literature (more examples are provided
in this review in the following sections). However, it should
be noted that merely binding of circRNA to a miRNA does
not always result in miRNA suppression. For example, when
ciRS-7 is bound to miR-671 it becomes susceptible to cleavage
by Argonaute 2 (AGO2), thus releasing miR-7 in the process.
Therefore, circRNAs may act as a miRNA reservoir or mediate
their transportation (Kristensen et al., 2018).
Interestingly, certain circRNAs have the potential to
be translated into protein in a process that requires N6-
methyladenosine (m6A) RNA base modification, the initiation
factor eukaryotic translation initiation factor 4 gamma (elF4G2),
methyltransferase-like 3 (METTL3), and methyltransferase-
like 14 (METTL14). Mass spectrometry and computational
prediction analyses demonstrated that there are hundreds of
endogenous circRNAs with the potential to be translated into
protein (Yang et al., 2017). For instance, circ-FBXW7 encodes
a 21 kDa protein known as F-Box and WD Repeat Domain
Containing 7 (FBXW7) – 185aa. Overexpression of this novel
protein reduced cellular proliferation and repressed glioma
tumorigenesis (Yang Y. et al., 2018).
Moreover, circRNA function may be extended to include
protein-binding activity and it has been suggested that circRNAs
are likely to be involved in protein binding, sorting, sequestering,
and modulating protein-protein interactions through scaffolding
properties. Based on bioinformatic analyses many circRNAs are
predicted to harbor RNA binding protein sites (Du et al., 2017b).
However, due to the tertiary structure of circRNAs the protein
binding function appears to be a more complicated process than
previously thought (Du et al., 2017b). Nevertheless, there are few
reports demonstrating the protein binding capacity of circRNAs.
For instance, Argonaute proteins, which are involved in miRNA
trafficking, were found to strongly interact with human circRNA
cerebellar degeneration-related protein 1 transcript (CDR1as) by
using the technique photoactivatable-ribonucleoside-enhanced
crosslinking and immunoprecipitation or PAR-CLIP (Memczak
et al., 2013). Additionally, the circRNA circMbl generated from
exon 2 of the splicing factor muscleblind (MBL/MBNL1) in
both drosophila and humans carries highly conserved binding
sites for the RNA binding protein MBL in both the flanking
introns and within the circularized exon 2. The authors further
demonstrated a strong and specific binding of MBL to the
circRNA, and this interaction was essential for increased circMbl
expression by exogenous expression of MBL (Ashwal-Fluss
et al., 2014). CircRNAs as well as their various functions are
summarized in Table 1.
circRNAs as Regulator of miRNA
Function
There is a breadth of evidence to support the sponging effect (as
competing endogenous RNA) regarding miRNAs of circRNAs
in a tissue or organ specific manner. The following section
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TABLE 1 | Summary of circRNAs and their functions in health and disease.
circRNA Species Function Target microRNA References
Circrnas as Regulator of Mirna Function
CDR1as Mouse
Zebrafish
Impair brain development miR-7 Memczak et al., 2013
Sry Human Testis-specific miR-138 Hansen et al., 2013
circHIPK3 Human Regulates cell growth miR-124 Zheng et al., 2016
circCOL3A1-859267 Human Collagen type expression miR29c Peng et al., 2018
circZfp609 Mouse Suppresses the myogenic differentiation miR-194-5p Wang et al., 2019
circRNA.2837 Rat Render neurons susceptible to neurological damage miR-34 family Zhou et al., 2018b
Oncogenic Circrnas
has_circ_0078710 Human Involved in hepatocellular carcinoma development by
increasing expression of HDAC and CDK2
miR-31 Xie et al., 2018
circFBLIM1 Human Hepatocellular carcinoma miR-346 Bai et al., 2018
circ_0001721 Human Facilitates the progression of osteosarcoma malignancy miR-569, miR-599 Li L. et al., 2018
circ_0016760 Human Involves in non-small cell lung cancer by regulating GAGE1
expression
miR-1287 Li Y. et al., 2018
The circ_0007534 Human Pancreatic ductal adenocarcinoma miR-625, miR-892b Hao et al., 2019
circUVRAG Human Mouse Bladder cancer miR-223 Yang et al., 2019
circ_0058063 Human Bladder cancer miR145-5p Sun et al., 2019
circ-U2AF1 Human Glioma malignancy miR-7-5p Li et al., 2019
circ-UBAP2 Human Triple-negative breast cancer miR-661 Wang et al., 2018
Tumor Suppressor Circrnas
circ-ITCH Human Mouse Bladder cancer inhibition by up regulation of p21 and PTEN miR-17, miR-224 Yang C. et al., 2018
Cdr1/ciRS-7 Human Mouse Bladder cancer miR-135a Li P. et al., 2018
circMTO1 Human Hepatocellular carcinoma miR-9 Han et al., 2017
circC3P1 Human Hepatocellular carcinoma miR-4641 Zhong et al., 2018
circ_0026344 Human Colorectal cancer miR-21, miR-31 Yuan et al., 2018
Circrnas and Kidney
circHLA-C human Lupus glomerulonephritis miR-150 Luan et al., 2018
ciRs-126 Human Acute kidney injury miR-126-5p Kolling et al., 2018
circRNA_1297 circRNA
0528
Rat kidney calculi circRNA_162 rno-miR_672-5p Lu et al., 2016; Cao
et al., 2018
Circrnas and Cardiovascular Disease
circANRIL Human Atherosclerosis and modulates PES1 Not identified Holdt et al., 2016
circ_010567 Mouse Diabetic mice myocardium and cardiac fibroblasts miR-141 Zhou and Yu, 2017
circRNA MFACR Mouse Myocardial infarction miR-652-3p Wang K. et al., 2017
The autophagy-related
circular RNA (ACR)
Mouse Heart ischemia/reperfusion injury. Represses Pink1 and
FAM65B
Not identified Zhou L. Y. et al., 2018
rno-circ_0056717 Rat Balloon-injured carotid artery Not identified Xu et al., 2018
hsa_circ_0037911 Human Essential hypertension marker Not identified Bao et al., 2018
circRNA_000203, and
circRNA_010567
Mouse Overexpressed in the myocardium of diabetic mice and in
cardiac fibroblasts
miR-26b-5p, miR-141 Tang et al., 2017; Zhou
and Yu, 2017
Circrnas in Other Diseases
circANKRD36 Human Type 2 diabetes mellitus hsa-miR-498, hsa-miR501-5p,
and hsa-miR-3614-3p
Fang et al., 2018
circ_0005015 Human Diabetic retinopathy miR-519d-3p Zhang et al., 2017
circRNA_Atp9b Mouse Mouse osteoarthritis miR-138-5p Zhou et al., 2018a
hsa_circRNA_102682,
has_CircRNA_104820,
has_circRNA_100782
Human Up regulated in pre-eclampsia Not identified Qian et al., 2016
circ_101222 Human Pre-eclampsia predictor Not identified Zhang et al., 2016
hsa_circ_0000650 Human Hepatitis B miR-6873-3p Zhou T. C. et al., 2018
circ-Foxo3 Human Mouse Cellular senescence by interacting with CDK2 and p21 Not identify Du et al., 2016, 2017a
hsa_circ_0005836,
hsa_circ_0009128
Human Active pulmonary tuberculosis markers Not identified Zhuang et al., 2017
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describes several selected examples that demonstrate the specific
sponging role of circRNAs in various tissues. The circRNA
sponging function was elegantly demonstrated by Memczak
et al. in their seminal study. They described the sponging
function of a circRNA CDR1as or ciRS-7. This circRNA was
shown to harbor 74 miR-7 seed matches suggesting a strong
interaction between this circRNA and its miRNA target. The
interplay between CDR1as and miR-7 was demonstrated to be
specific to neuronal tissue in adult and embryonic mouse brain.
CDR1as overexpression and the resulting inhibtion of miR-7 by
morpholinos in zebrafish resulted in reduction of midbrain size
(Memczak et al., 2013). Similarly, the testis specific circRNA sex-
determining region Y (Sry) was shown to particularly sponge
miR-138 and regulate its function in an in vitro study using
HEK293 cellls (Hansen et al., 2013). The circRNA derived from
exon 2 of the homeodomain-interacting protein kinase 3 (HIPK3)
gene, circHIPK3 is thought to have the potential to sponge up
to 9 different miRNAs with an estimation of 18 binding sites.
There was a significant inhibition of cell growth upon circHIPK3
silencing in the human hepatocyte cell line HuH-7. Moreover
the authors demonstrated direct binding to and sponging of
miR-124 thus regulating its activity (Zheng et al., 2016). The
expression of type 1 collagen is regulated by circCOL3A1-859267
in human dermal fibroblasts. Although this circRNA contains
putative binding sites to several miRNA (e.g., miR29a-c, miR-
767, and miR-133a), only miR29c was identified to be a target of
circCOL3A1-859267. Overexpression of miR29c decreased type
1 collagen expression. However, this effect was abrogated by the
introduction of circCOL3A1-859267 using a lentivirus expression
system (Peng et al., 2018). In skeletal muscle development the
circular RNA zinc finger protein 609 (circZfp609) suppressed the
myogenic differentiation in mouse myoblast cell line C2C12 by
sponging up miR-194-5p that regulates the expression of BCL2-
associated transcription factor (BCLAF1) (Wang et al., 2019).
Lastly, the suppression of circRNA.2837 expression may protect
neurons from neurological damage in a rat sciatic nerve injury
model since circRNA.2837 acts as a sponge to members of the
miR-34 family (Zhou et al., 2018b).
circRNAs and Cancer
Since the identification of circRNA sponging of miRNA that are
involved in cancer pathogenesis, a multitude of studies have been
forwarded regarding the association of circRNAs with various
human cancers (Kristensen et al., 2018). Given the biomarker
potential of circRNAs as well as the their proposed future use as
therapeutic agents, it is imperative to improve our understanding
how circRNAs and their miRNA targets are regulated in the
development and progression of cancer. Therefore, in this review
we will highlight the current findings that implicate certain
circRNAs in cancer development and growth, in contrast to other
circRNAs that act as tumor suppressors.
Oncogenic circRNAs
Several studies have outlined the sponging activity of certain
circRNAs with regard to miRNAs, which are critical regulators of
oncogenes in tumor development. For instance, overexpression
of hsa_circ_0078710 increased cellular proliferation and
migration, tumor growth and migration in human hepatocellular
carcinoma (HCC) cell lines HepG2 and SMMC-7721 by
sponging miR-31, increasing the expression levels of histone
deacetylase 2 (HDAC2) and cyclin-dependent kinase 2 (CDK2)
(Xie et al., 2018). In another HCC study the downregulation
of the circRNA filamin-binding LIM protein 1 (circFBLIM1)
reduced cellular proliferation and invasion, and concomitantly
induced apoptosis in human HCC cell lines HepG2, 7402,
and 97H. CircFBLIM1 acts as a competitive endogenous RNA
to filamin-binding LIM protein 1 (FBLIM1) and by binding
to miR-346 which targets FBLIM1 mRNA (Bai et al., 2018).
Circ_0001721 sponges miR-569 and miR-599 and facilitates the
progression of osteosarcoma malignancy in humans. Therefore,
the expression of circ_0001721 can be used as an unfavorable
predictor of disease progression in osteosarcoma patients (Li L.
et al., 2018). The oncogenic effect of circ_0016760 is attributed to
the sponging activity of miR-1287 and the increased expression
of cancer/testis antigen family 4 member 1 (GAGE1) in non-
small cell lung cancer human cell lines A549 and H1299 (Li Y.
et al., 2018). Circ_0007534 is found upregulated in patients with
pancreatic ductal adenocarcinoma (PDAC). Overexpression of
this circRNA was associated with advanced tumor stage and
invasion of the lymph node. Further analysis revealed that
overexpression of circ_0007534 in the human PDAC cell line
SW1990 led to increased migration, proliferation, and invasion.
Circ_0007534 mediates its oncogenic effect by sponging miR-
625, and miR-892b (Hao et al., 2019). The downregulation of the
circRNA UV radiation resistance-associated gene (circUVRAG)
expression suppressed proliferation and metastasis of bladder
cancer in vitro using the human bladder cancer cell line UM-UC-
3 and in vivo using Balb/c nude mice injected with lentivirally
stabilized circUVRAG UM-UC-3 into the right flank. The effects
of circUVRAG are attributed to a mechanism that involves
miR-223 sponging and downregulation of fibroblast growth
factor receptor 2 (FGFR2) (Yang et al., 2019). Similarly, the
oncogenic effect of circ_0058063 was demonstrated in another
bladder cancer study. The suppression of circ_0058063 reduced
cellular proliferation and migration and induced apoptosis in the
human bladder cancer cell lines T24 and J82. The sponging of
miR145-5p, which regulates cyclin-dependent kinase (CDK6), is
a key element of the function of circ_0058063 in the development
and progression of bladder cancer (Sun et al., 2019). In a human
glioma malignancy study the circRNA U2 auxiliary factor
35 kDa subunit (circ-U2AF1) was found upregulated along
with neuro-oncological ventral antigen 2 (NOVA2). Suppression
of circ-U2AF1 resulted in decreased expression of NOVA2
and an increase in expression of miR-7-5p both in vitro and
in vivo. As a result, silencing of circ-U2AF1 decreased cellular
proliferation, migration and invasion, and increased cell death
by apoptosis in the human glioma cell lines U87MG, and U251.
Luciferase assay demonstrated that miR-7-5p is a direct target
of circ-U2AF1 (Li et al., 2019). In triple-negative breast cancer
(TNBC) circ-UBAP2 was found upregulated and associated with
larger tumor size. The microRNA miR-661, which regulates the
expression of the metastasis-associated gene (MTA1), was found
to be a direct target of circ-UBAP2. Suppression of circ-UBAP2
induced apoptosis and decreased proliferation and migration
Frontiers in Pharmacology | www.frontiersin.org 5 April 2019 | Volume 10 | Article 428
fphar-10-00428 April 24, 2019 Time: 17:27 # 6
Haddad and Lorenzen Circular RNAs in Health and in Disease
of the human TNBC cell lines BT-20 and MDA-MB-231
(Wang et al., 2018).
Tumor Suppressor circRNAs
Many studies have shown the remarkable potential that circRNAs
may have in the future as an anti-cancer treatment option. The
anti-tumor activity of the circRNA itchy E3 ubiquitin protein
ligase (circ-ITCH) was demonstrated in human bladder cancer
tissue and in human bladder cancer cell lines EJ and T24.
The overexpression of circ-ITCH inhibited cellular migration,
proliferation, and metastasis in vitro and also suppressed cancer
formation of xenografts in Balb/c nude mice in vivo. The
mechanism of circ-ITCH function is demonstrated by the up-
regulation of the tumor suppressor genes p21 and phosphatase
and tensin homolog (PTEN) expression due to the sponging
effect of circ-ITCH to both miR-17 and miR-224 (Yang C.
et al., 2018). Similarly, in another bladder cancer study the
circRNA Cdr1 (also known as ciRS-7) is downregulated in cancer
cells as compared to normal adjacent tissue. Overexpression
of Cdr1 reduced cellular proliferation, migration, and invasion
in the human bladder cancer cell lines EJ and T24 in vitro,
and retarded tumor growth in Balb/c nude mice in vivo.
The observed anti-oncogenic effect of Cdr1 is attributed to
the sponging function of miR-135a (Li P. et al., 2018). Han
et al. performed a global circRNA expression analysis using
289 human samples of HCC and paired adjacent liver tissues
to identify dysregulated circRNA expression in HCC samples.
Here, the circRNA mitochondrial tRNA translation optimization 1
(circMTO1) was found to be significantly downregulated. Further
analysis showed that suppression of circMTO1 led to increased
proliferation and invasion of the human HCC cell lines HepG2
and SMMC-7721. CircMTO1 exerts its anti-tumor activity by
sponging oncogenic miR-9 and thus preserving the expression
of p21 (Han et al., 2017). The expression level of the circRNA
complement component 3 precursor pseudogene (circC3P1) is
significantly downregulated in HCC and the expression level of
this circRNA is inversely correlated with tumor size and vascular
invasion. In contrast, overexpression of circC3P1 decreased
cellular migration, proliferation and invasion in human HCC
Hep3B and MHCC97-L via a mechanism that involves sponging
of miR-4641 and increased expression of phosphoenolpyruvate
carboxykinase 1 (PCK1) (Zhong et al., 2018). Yuan et al. screened
32 pairs of human colorectal cancer (CRC) tissues and adjancent
normal tissues and identified circ_0026344 to be downregulated
in CRC tissues, whereas miR-21 and miR-31 expression levels
were elevated. The ectopic expression of circ_0026344 induced
apoptosis and reduced tumor growth and invasion in human
CRC cell lines SW480 and HT29 via a mechanism that involves
miR-21 and miR-31 sponging (Yuan et al., 2018).
circRNAs and Kidney
The function of circRNAs in kidney homeostasis and disease
pathogenesis remains largely unexplored. The few available
studies, however, suggest that circRNAs may be used as promising
biomarkers in blood (Memczak et al., 2015) and urine (Vo
et al., 2019) of patients and may serve as therapeutic targets in
kidney disease. Luan et al. performed a circRNA profiling in 6
kidney biopsies of patients with lupus nephritis (LN) compared
to 5 healthy kidney tissues. Consequently, 171 circRNAs with at
least twofold differential expression were identified. Interestingly,
the expression of circHLA-C correlated positively with renal
activity index, serum creatinine, proteinuria, and crescentic
glomureli. The expression of circHLA-C in patients with LN
was increased 2.72-fold compared to controls. This increased
expression coincided with a 66% reduction in expression of miR-
150 in LN patients. The authors argued that the sponging of
miR-150 could be a factor in the pathogenesis of LN (Luan
et al., 2018). In a global circRNA analysis of RNA extracted
from blood of patients with acute kidney injury (AKI) three
novel circRNAs were upregulated in the blood of AKI patients
as compared to control. Most notably, the circRNA circular RNA
sponge of miR-126 (ciRs-126) was found to be an independent
predictor of 28 days survival of patients with acute kidney
injury (AKI). In this study miR-126-5p was downregulated in
AKI patients and in hypoxic endothelial cells. This effect is
attributed to the potential sponging function of ciRs-126 of its
target miR-126-5p (Kolling et al., 2018). Wang et al studied the
expression of circRNAs in uremia due to glomerulonephritis.
They screened a total of 20 individuals, 10 healthy controls as
well as 10 patients without systemic lupus erythematosus, for
the presence of circRNAs in plasma and peripheral mononuclear
cells (PBMCs). The research group identified 385-upregulated
and 325 downregulated circRNAs in plasma. In addition, 670
upregulated and 298 downregulated circRNAs were found in
PBMCs. The differentially expressed circRNAs relate to various
cellular functions including signal transduction, migration, cell
differentiation, immune responses and other functions. For
example, the regulated circRNAs target genes include ring
finger protein 41 (RNF41), ST6 beta-galactoside alpha-2,6-
sialtransferase (ST6GAL1), WD repeat-containing protein 37
(WDR37), notch homolog 1, translocation-associated (Notch),
protein phosphatase 2, regulatory subunit B′, alpha subunit
(PPP2R5A), adaptor related protein complex 4 subunit Mu 1
(AP4M1), and presenilin 1 (PSEN1). The authors suggest that
this study could potentially provide diagnostic biomarkers for the
diagnosis and prognosis of patients with uremia (Wang X. et al.,
2017). The expression profiles of circRNAs in normal and fetal
human tissues using RNA-seq identified 474 circRNAs with adult
kidney specific expression and 7962 circRNAs expressed in the
human fetal kidney. These results suggest that circRNAs function
in a tissue specific manner (Xu et al., 2017). In a rat model
of ethylene glycol-induced kidney calculi the expression profiles
of mRNA, circRNAs linear lncRNAs were determined. In this
animal model 145 circRNAs were deregulated in rat kidney with
urolithiasis. Interestingly, circRNA_1297 was associated with
rno-miR-138-5p, but circRNA_0528, and circRNA_162 were
associated with rno-miR_672-5p. The two microRNAs have been
demonstrated to play a role in the development of hypercalciuria
urolithiasis (Lu et al., 2016; Cao et al., 2018).
circRNAs and Cardiovascular Diseases
The role of circRNA in the pathogenesis of cardiovascular
diseases is a heavily reviewed topic (Fan et al., 2017; Althesha
et al., 2018; Carrara et al., 2018; Holdt et al., 2018a,b; Ste˛pien´
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et al., 2018; Zhou M. Y. et al., 2018). Therefore a summary of
the major findings will be described here. The atherosclerosis
protective circRNA antisense non-coding RNA in the INK4 locus
(circANRIL) modulates the function of pescadillo homologue
1 (PES1), an important 60S-preribosomal assembly factor,
and protects against atherogenesis by modulating ribosomal
RNA (rRNA) maturation in human smooth muscle cells and
macrophages, thereby inducing apoptosis and inhibiting cellular
proliferation (Holdt et al., 2016). In a mouse study, the expression
of circ_010567 was increased in diabetic mice myocardium
and cardiac fibroblasts via a mechanism that involved miR-
141 sponging and upregulation of transforming growth factor
beta 1 (TGFβ1) expression. The suppression of circ_010567
expression reduced fibrotic protein expression such as Collagen
1, Collagen 3 and alpha smooth muscle actin (αSMA) in
mouse cardiac fibroblasts, (Zhou and Yu, 2017). The circRNA
MFACR (mitochondrial fission and apoptosis-related circular
RNA) targets miR-652-3p specifically that leads to mitochondrial
fission inhibition and a reduction of cardiomyocyte apoptosis by
decreasing the expression of mitochondrial protein 18 (MTP18).
In a mouse model of myocardial infarction (MI), suppression
of MFACR in cardiomyocytes decreased mitochondrial fission
and notably myocardial infarction (Wang K. et al., 2017).
The function of circRNAs in the regulation of autophagy in
cardiovascular diseases was demonstrated by Zhou et al. The
Autophagy-related circular RNA (ACR) has a protective role in
the heart against ischemia/reperfusion injury in a mouse model
of myocardial infarction by repressing autophagy through a
process that involves PTEN induced putative kinase 1 (Pink1)
activation, family with sequence similarity 65, member B
(FAM65B) phosphorylation, and the blocking of Pink1 promoter
DNA methylation mediated by DNA methyltransferase 3 beta
(Dnmt3B) (Zhou L. Y. et al., 2018). In a rat model of balloon-
injury of the carotid artery, the diaphanous related formin 3
(Diaph3) derived circRNA rno-circ_0056717 (circDiaph3) was
identified in a microarray and the suppression of this circRNA
increased insulin-like growth factor 1 receptor (Igf1r) expression
and stimulated vascular smooth muscle cell proliferation and
migration (Xu et al., 2018). In an essential hypertension (EH)
study that included 200 patients, the circRNA hsa_circ_0037911
was significantly overexpressed in EH patients and the authors
suggest that this circRNA could be an effective marker of
EH (Bao et al., 2018). The circRNAs circRNA_000203, and
circRNA_010567 are overexpressed in the myocardium of
diabetic mice and in cardiac fibroblasts in a cardiac fibrosis
mouse model related to Angiotensin II (Ang II). Overexpression
of circRNA_000203 in mouse cardiac fibroblasts resulted in a
promotion of the expression of collagen-1-α2 (col1a2), collagen-
3-α1 (col3a1) and αSMA via a mechanism of sponging miR-
26b-5p. Additionally, the downregulation of circRNA_010567 in
cardiac fibroblasts resulted in suppression of TGFb1 expression,
which is a target of miR-141, and the decreased expression of
fibrosis related genes (Tang et al., 2017; Zhou and Yu, 2017).
circRNAs in Other Diseases
The role that circRNAs play in disease protection or development
extends to several other diseases that have been already reported.
For instance, the circRNA derived from the gene ankyrin
repeat domain-containing protein 36A (circANKRD36) was
overexpressed in peripheral leucocytes of patients with type
2 diabetes mellitus (T2DM). The expression of circANKRD36
positively correlated with higher glucose and glycosylated
hemoglobin levels. In addition, the expression levels of
interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-
alpha) were significantly increased in the peripheral blood of
patients with T2DM. The authors suggest an involvement of
circANKRD36 in the increased inflammatory response in T2DM
patients through a mechanism that involves the regulation
of miRNAs, hsa-miR-498, hsa-miR501-5p, and hsa-miR-3614-
3p (Fang et al., 2018). In diabetic retinopathy patients the
expression of circ_0005015 was elevated in the fibrovascular
membranes, the plasma and the vitreous sample, which resulted
in enhanced endothelial angiogenic responses via sponging miR-
519d-3p and increased expression of matrix metallopeptidase
2 (MMP-2), signal transducer and activator of transcription 3
(STAT3), and X-linked inhibitor of apoptosis (XIAP) (Zhang
et al., 2017). The function of circRNA derived from the
gene ATPase phospholipid transporting 9B (circRNA_Atp9b)
was examined in a mouse osteoarthritis chondrocyte cell
model. CircRNA_Atp9b expression level was elevated in mouse
chondrocytes in response to interleukin-1β (Il-1β) treatment.
Suppression of CircRNA_Atp9b expression resulted in decreased
matrix metallopeptidase 13 (MMP13), interleukin-6 (IL-6), and
cyclooxygenase 2 (COX-2) expression while type II collagen
was increased. The regulatory function of circRNA_Atp9b in
the progression of osteoarthritis is attributed to the sponging
of miR-138-5p in mouse chondrocytes (Zhou et al., 2018a).
In a study involving placental tissues to identify circRNA
dysregulation in pre-eclampsia by microarray, 143 circRNAs
were induced, while 158 were repressed as compared to
controls. The top three circRNAs that were significantly
upregulated were hsa_circRNA_102682, hsa_circRNA_104820
and hsa_circRNA_100782 (Qian et al., 2016). However the
function of these circRNAs in the pathogenesis of pre-eclampsia
has not been elucidated to date. Similarly, circ_101222 could
be used as pre-eclampsia predictor in combination with the
expression levels of endoglin in plasma (Zhang et al., 2016).
RNA sequencing involving liver biopsies of chronic hepatitis
B virus infection revealed a total of 99 dysregulated circRNAs
as compared to control. Computational and regression analyses
showed a positive correlation between hsa_circ_0000650 and
TGF-beta-2 with a possible interaction between miR-6873-
3p and TGF-beta-2. Taken together these results suggest an
involvement of circRNAs in the pathogenesis of hepatitis B
virus infection and the progression of liver disease (Zhou
T. C. et al., 2018). New evidence implicates circRNAs in aging
and cellular senescence. Results of RNA-seq from cortex and
hippocampus of young as compared to aged mice showed a
significant accumulation of circRNAs in brain tissues (Gruner
et al., 2016). The circRNA derived from forkhead box O3 (Foxo3)
gene termed circ-Foxo3 is implicated in cellular senescence
as overexpression of this circRNA promoted senescence while
silencing circ-Foxo3 suppressed cellular senescence. Circ-Foxo3
exerts its effects by binding to cyclin-dependent kinase 2
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(CDK2) and the cell cycle inhibitor p21 (Du et al., 2016,
2017a). Two circRNAs hsa_circ_0005836 and hsa_circ_0009128
were identified using high-throughput sequencing to be
downregulated in PBMCs in patients with active pulmonary
tuberculosis compared to controls. However, the authors suggest
that only hsa_circ_0005836 could be used potentially as a novel
tuberculosis biomarker (Zhuang et al., 2017).
CONCLUSION
The elucidation of the function of circRNAs is an emerging field
of science with a tremendous potential after previously being
dismissed as RNA artifacts. They are ubiquitously expressed and
thousands of members have already been identified. This fact only
expands their potential to possibly enhance our knowledge to
understand the difference between health and disease. Owing to
their structure stability and their presence in exosomes circRNAs
may also exert their function in an autocrine, paracrine and
possible endocrine fashion. In addition, the fact that circRNAs
are widely distributed in the cellular compartment as well as
in the extracellular space in various body fluids affords them
to become ideal candidates as reliable biomarkers for various
human diseases. As in any emerging field caution is advised in
interpreting new findings. To date studies are merely descriptive
in nature. More in depth analysis about the function and
regulation of identified circRNAs is needed to understand their
mechanism of action. These RNA molecules hold great promise
as biomarkers of disease because of their high resistance to
exonuclease activity and might even be more highly expressed
than their linear counterparts. Especially their putative role
as miRNA sponges makes them interesting targets for future
investigations. In the future circRNA-based therapies might be
introduced. The concept of establishing circRNAs as therapeutics
in the future relies on the stability and expression in distinct
organs and their specificity for a certain disease. The more
specific circRNAs are to a specific organ or disease, the less
likely it is to encounter off-target effects, while therapeutically
modulating a specific circRNA in a disease setting. As is known
for microRNA the likelihood of ensuing significant and undesired
off-target effects greatly limits the use of these transcripts as
therapeutics. The elucidation of the role of specific circRNAs is
the prerequisite for a targeted RNA–based therapy for a specific
disease. Tissue/cell specificity might be achieved by coupling
ncRNAs to tissue-specific antibodies and/or peptides, thereby
reducing off-target effects.
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